Free Trial

2,498 Shares in Plexus Corp. (NASDAQ:PLXS) Acquired by Sherbrooke Park Advisers LLC

Plexus logo with Computer and Technology background

Sherbrooke Park Advisers LLC purchased a new position in Plexus Corp. (NASDAQ:PLXS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,498 shares of the technology company's stock, valued at approximately $391,000.

Other institutional investors have also recently made changes to their positions in the company. TD Private Client Wealth LLC purchased a new position in Plexus in the 4th quarter valued at $28,000. Aquatic Capital Management LLC raised its position in shares of Plexus by 134.0% in the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after buying an additional 134 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Plexus in the fourth quarter valued at about $45,000. Nomura Asset Management Co. Ltd. lifted its stake in shares of Plexus by 45.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company's stock worth $50,000 after buying an additional 100 shares in the last quarter. Finally, Blue Trust Inc. boosted its position in Plexus by 12.1% during the fourth quarter. Blue Trust Inc. now owns 776 shares of the technology company's stock worth $121,000 after acquiring an additional 84 shares during the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Stifel Nicolaus set a $145.00 price target on shares of Plexus in a research report on Thursday, April 24th. Needham & Company LLC reissued a "buy" rating and issued a $162.00 target price (down from $172.00) on shares of Plexus in a report on Friday, April 25th. Finally, Benchmark restated a "buy" rating and issued a $160.00 price objective on shares of Plexus in a research note on Friday, May 16th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, Plexus presently has a consensus rating of "Moderate Buy" and a consensus price target of $155.67.

Get Our Latest Stock Analysis on Plexus

Plexus Price Performance

Plexus stock traded down $1.91 during mid-day trading on Wednesday, reaching $130.26. The company had a trading volume of 115,370 shares, compared to its average volume of 168,733. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The stock's 50-day simple moving average is $125.33 and its 200-day simple moving average is $142.84. Plexus Corp. has a 1 year low of $100.96 and a 1 year high of $172.89. The company has a market capitalization of $3.53 billion, a P/E ratio of 30.22 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The technology company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.54 by $0.12. Plexus had a net margin of 3.03% and a return on equity of 10.36%. The business had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. During the same period in the prior year, the business earned $0.94 earnings per share. The company's quarterly revenue was up 1.4% on a year-over-year basis. On average, equities analysts predict that Plexus Corp. will post 5.9 EPS for the current year.

Insider Activity

In other Plexus news, insider Michael J. Running sold 1,250 shares of the firm's stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $138.62, for a total transaction of $173,275.00. Following the sale, the insider now directly owns 1,276 shares of the company's stock, valued at $176,879.12. This trade represents a 49.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Patrick John Jermain sold 4,328 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $132.29, for a total transaction of $572,551.12. Following the completion of the transaction, the chief financial officer now directly owns 25,637 shares of the company's stock, valued at approximately $3,391,518.73. This represents a 14.44% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.76% of the company's stock.

Plexus Company Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines